Ciprofloxacin resistance emerges in Neisseria gonorrhoeae in Victoria, 1998 to 2001

Authors

  • Mark Veitch Microbiological Diagnostic Unit, Public Health Laboratory, Department of Microbiology and Immunology, the University of Melbourne, Melbourne VIC 3010
  • Julia M Griffith Sexually Transmissible Infections and Hepatitis C Program, Communicable Diseases Section, Victorian Department of Human Services, Victoria
  • Melissa L Morgan Sexually Transmissible Infections and Hepatitis C Program, Communicable Diseases Section, Victorian Department of Human Services, Victoria

DOI:

https://doi.org/10.33321/cdi.2003.27.26

Keywords:

Neisseria gonorrhoeae, ciprofloxacin, antibiotic resistance

Abstract

Notifications of gonorrhoea in Victoria increased suddenly in the late 1990s, from an average of 375 cases per year from 1993 to 1997, to over 700 cases in 2000. This paper describes the susceptibility to ciprofloxacin of isolates of N. gonorrhoeae in Victoria from 1998 to 2001, and relates these to the reported epidemiologic characteristics of the cases. The proportion of all isolates of N. gonorrhoeae that was resistant to ciprofloxacin rose from 3 per cent in 1998 to 11 per cent in 2001. Among homosexual and bisexual men, resistant isolates remained rare (< 1 per cent). Among heterosexual men and women whose infection was acquired overseas, the proportion of resistant isolates increased from 14 per cent to 51 per cent. Among heterosexual men and women whose infection was acquired in Australia, the proportion of resistant isolates increased from 6 per cent to 14 per cent, and disproportionately involved persons born overseas. Patterns of antibiotic resistance are intimately linked to epidemiological characteristics of cases. Clinical treatment and public health and control strategies for resurgent sexually transmitted infections benefit from the insights of collaborative microbiological and epidemiological surveillance. Commun Dis Intell 2003;27 Suppl:S75-S79.

Downloads

Download data is not yet available.

References

O'Grady K-A, Tallis G, eds. Surveillance of Notifiable Infectious Diseases in Victoria 2000. Communicable Diseases Section, Public Health Division, Victorian Department of Human Services; 2001.

Surveillance report. Victorian Infectious Diseases Bulletin 2002;5:7-15.

Spicer J. (Chairman of Writing Group) Therapeutic guidelines: antibiotic. (Version 11) North Melbourne: Therapeutic Guidelines Limited; 2000.

Bowden FJ, Tabrizi SN, Garland SM, Fairley CK. Sexually transmitted infections: new diagnostic approaches and treatments. Med J Aust 2002;176:551-557.

Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme, 2000. Commun Dis Intell 2001;25:59-63.

WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell 2001;25:274-276.

Australian Gonococcal Surveillance Programme. Use of a quality assurance scheme in a long-term multicentric study of antibiotic susceptibility of Neisseria gonorrhoeae. Genitourin Med 1990;66:437-444.

Berglund T, Unemo M, Olcen P, Giesecke J, Fredlund H. One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS 2002;13:109-114.

Tapsall JW. The biology of Neisseria gonorrhoeae: a model of adaptation and survival. Venereology 2000;13:63-69.

Downloads

Published

30/05/03

How to Cite

Veitch, Mark, Julia M Griffith, and Melissa L Morgan. 2003. “Ciprofloxacin Resistance Emerges in Neisseria Gonorrhoeae in Victoria, 1998 to 2001”. Communicable Diseases Intelligence 27 (May):S75-S79. https://doi.org/10.33321/cdi.2003.27.26.

Most read articles by the same author(s)